FDA Chief In India Departs
Posted at noon on July 23
CQ HealthBeat’s Kerry Young reports on the departure of the Food and Drug Administration’s India office chief, Altaf Lal.
Lal returned to the United States in May and has since left the FDA, the agency said. “The FDA has nothing further to share,” it said in a written statement. (Young has more on CQ.com for subscribers.)
A business newspaper in India, citing pharmaceutical company sources, reported that Lal was “not comfortable with the way [the office] was functioning and their role during the inspection process.”
The FDA has a presence in India to spearhead inspections of drug manufacturing facilities and products exported to the United States.